Clinical Trial Update: Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy [Phase 3]

View source ↗

Summary

A Phase 3 trial reports that Sodium Zirconium Cyclosilicate lowers hyperkalemia after parathyroidectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperkalemia
• Hyperparathyroidism Secondary

Drugs mentioned

• Sodium Zirconium Cyclosilicate (sodium zirconium cyclosilate)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Sodium Zirconium Cyclosilicate, Hyperkalemia | Phase 3 | Status: COMPLETED